99
Views
11
CrossRef citations to date
0
Altmetric
Original Research

The value of the plasma circulating cell-free DNA concentration and integrity index as a clinical tool for prostate cancer diagnosis: a prospective case–control cohort study in an Iranian population

, , , , &
Pages 4549-4556 | Published online: 16 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Giovanni Ponti, Monia Maccaferri, Antonio Percesepe, Aldo Tomasi & Tomris Ozben. (2021) Liquid biopsy with cell free DNA: new horizons for prostate cancer. Critical Reviews in Clinical Laboratory Sciences 58:1, pages 60-76.
Read now
Fernando Luiz Affonso Fonseca, Glaucia Luciano da Veiga, Beatriz da Costa Aguiar Alves & Sarah Isabel Pinto Monteiro do Nascimento Alves. (2021) Liquid Biopsy in Cancer using the Z-Scan Technique: A New Approach to Discover Biomarkers in Cancer. Future Science OA 7:1.
Read now

Articles from other publishers (9)

Madhumathy G. Nair, Rakesh S. Ramesh, Chandrakala M. Naidu, Apoorva D. Mavatkar, Snijesh V. P., Vishakha Ramamurthy, Vidya M. Somashekaraiah, Anupama C. E.Kiruthiga Raghunathan, Anuradha Panigrahi, Manjula Das, Sujan K. Dhar & Jyothi S. Prabhu. (2023) Estimation of ALU Repetitive Elements in Plasma as a Cost-Effective Liquid Biopsy Tool for Disease Prognosis in Breast Cancer. Cancers 15:4, pages 1054.
Crossref
Samaneh Eickelschulte, Anja Lisa Riediger, Arlou Kristina Angeles, Florian Janke, Stefan Duensing, Holger Sültmann & Magdalena Görtz. (2022) Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer. Cancers 14:24, pages 6094.
Crossref
Sonu Kumar, Neeti Nadda, Shashi Paul, Shivanand Gamanagatti, Nihar Ranjan Dash, Perumal Vanamail, Anoop Saraya, Shalimar & Baibaswata Nayak. (2022) Evaluation of the cell-free DNA integrity index as a liquid biopsy marker to differentiate hepatocellular carcinoma from chronic liver disease. Frontiers in Molecular Biosciences 9.
Crossref
Semaa Shaban, Aya Al‑Rahim & Ahmed Suleiman. (2022) ALU repeat as potential molecular marker in the detection and prognosis of different cancer types: A systematic review. Molecular and Clinical Oncology 16:4.
Crossref
Seyed Mohammad Kazem Aghamir, Amirhossein Rahimnia, Seyed Saeed Tamehri Zadeh & Hassan Roudgari. 2022. Liquid Biopsy in Urogenital Cancers and its Clinical Utility. Liquid Biopsy in Urogenital Cancers and its Clinical Utility 67 99 .
Julie Earl, Emma Barreto, María Castillo, Raquel Fuentes, Mercedes Rodríguez-Garrote, Reyes Ferreiro, Pablo Reguera, Gloria Muñoz, David Garcia-Seisdedos, Jorge López, Bruno SainzJr.Jr., Nuria Malats & Alfredo Carrato. (2021) Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. Cancers 13:7, pages 1612.
Crossref
Maryam Khani, Jalil Hosseini, Mohsen Habibi, Reza Mirfakhraie, Zahra Sadeghzadeh & Farkhondeh Pouresmaeili. (2020) Investigating the relationship between ccfDNA concentration, its integrity, and some individual factors in an Iranian population. Human Antibodies 28:4, pages 319-326.
Crossref
Andrew Condappa, Donovan McGrowder, William Aiken, Wayne McLaughlin & Maxine Gossell-Williams. (2020) Evaluation of Plasma Circulating Cell Free DNA Concentration and Integrity in Patients with Prostate Cancer in Jamaica: A Preliminary Study. Diseases 8:3, pages 34.
Crossref
Navid Sobhani, Marianna Sirico, Daniele Generali, Fabrizio Zanconati & Bruna Scaggiante. (2020) Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer. World Journal of Clinical Oncology 11:7, pages 450-463.
Crossref